Why Novocure Stock Fell 24.4% This Week
Novocure announced a disappointing outcome from a phase 3 clinical trial for a key cancer treatment.
Source: fool.com
📰 Novocure Ttfields News
Novocure Ttfields News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Novocure Ttfields. Real-time updates on events, politics, business and more.
Novocure Shares Plunge After Its Ovarian Cancer Treatment Fails to Meet Goal
Novocure shares plunged after the provider of cancer-fighting treatments reported a Phase 3 trial of its Tumor Treating Fields (TTFields) therapy for ovarian cancer patients failed to meet its goal.
Source: investopedia.com
Why NovoCure Stock Is Crashing Today | The Motley Fool
The company disappointed investors with its latest clinical trial update.
Source: fool.com
Should You Buy Novocure Stock Right Now?
Most Wall Street analysts think this stock will skyrocket. They could be right.
Source: fool.com
Tumor-Zapping Device Scores in Pivotal Study, Sends Shares of Novocure Soaring
Novocure’s electrical field-producing medical device, in combination with standard drug therapies, improved overall survival in a pivotal study that enrolled patients with advanced non-small cell lung cancer. The medtech company now plans to seek regulatory approvals.
Source: medcitynews.com
Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
Novocure chose Montreal because of its innovative culture, world-class universities and hospitals, access to top talent and quality of life Novocure (NASDAQ: NVCR) today announced it has opened a
Source: finanznachrichten.de